Skip Navigation



Brain Advance Access published online on May 5, 2004

Brain, doi:10.1093/brain/awh191
© 2004 by Guarantors of Brain
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
127/7/1670    most recent
awh191v2
awh191v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Saleh, A.
Right arrow Articles by Jander, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saleh, A.
Right arrow Articles by Jander, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received December 23, 2003
Revised March 10, 2004
Accepted March 14, 2004

Article

In vivo MRI of brain inflammation in human ischaemic stroke

Andreas Saleh 1, Michael Schroeter 2, Cornelia Jonkmanns 1, Hans-Peter Hartung 2, Ulrich Mödder 1, Sebastian Jander 2*

1 Institute of Diagnostic Radiology, University Hospital, Düsseldorf, Germany
2 Department of Neurology, University Hospital, Düsseldorf, Germany

* To whom correspondence should be addressed. E-mail: jander{at}uni-duesseldorf.de.


   Abstract

Inflammation contributes to brain damage caused by ischaemic stroke. Macrophages, as the prevailing inflammatory cell population in stroke lesions, can be visualized using ultrasmall superparamagnetic iron oxide (USPIO) as a cell-specific contrast agent for MRI. In this single-centre open-labelled clinical phase II study we tested the potential of USPIO-enhanced MRI for macrophage imaging in human ischaemic stroke lesions. In a series of 10 consecutive patients, USPIO contrast agent was infused at the end of the first week after symptom onset. Two follow-up MRI scans were performed 24-36 h and 48-72 h after infusion. Two distinct components of USPIO-related signal changes were discernible, one associated with blood vessels and one representing parenchymal enhancement. Vessel-associated changes appeared as signal loss on T2/T2-weighted images and decreased from the first to second scan after USPIO infusion, most likely reflecting a transient blood pool effect of the contrast agent. Conversely, parenchymal enhancement was mainly evident on T1-weighted images, increased over time, and matched with the expected distribution of macrophages. Importantly, USPIO-induced signal alterations throughout differed from signatures of conventional gadolinium-enhanced MRI, thus being independent from breakdown of the blood-brain barrier. We suggest that increasing USPIO-enhancement on T1-weighted images indicates brain infiltration by USPIO-laden macrophages. Thus, USPIO-enhanced MRI may provide an in vivo surrogate marker of cellular inflammation in stroke and other CNS pathologies.

Key Words: stroke; inflammation; magnetic resonance imaging; contrast media; macrophages


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Y. Tang, K. H. Muller, M. J. Graves, Z. Y. Li, S. R. Walsh, V. Young, U. Sadat, S. P.S. Howarth, and J.H. Gillard
Iron Oxide Particles for Atheroma Imaging
Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1001 - 1008.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. K. Reddy and V. Labhasetwar
Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury
FASEB J, May 1, 2009; 23(5): 1384 - 1395.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. Desestret, J.-C. Brisset, S. Moucharrafie, E. Devillard, S. Nataf, J. Honnorat, N. Nighoghossian, Y. Berthezene, and M. Wiart
Early-Stage Investigations of Ultrasmall Superparamagnetic Iron Oxide-Induced Signal Change After Permanent Middle Cerebral Artery Occlusion in Mice
Stroke, May 1, 2009; 40(5): 1834 - 1841.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Serres, D. C. Anthony, Y. Jiang, K. A. Broom, S. J. Campbell, D. J. Tyler, S. I. van Kasteren, B. G. Davis, and N. R. Sibson
Systemic Inflammatory Response Reactivates Immune-Mediated Lesions in Rat Brain
J. Neurosci., April 15, 2009; 29(15): 4820 - 4828.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. M. Vellinga, R. D. Oude Engberink, A. Seewann, P. J.W. Pouwels, M. P. Wattjes, S. M.A. van der Pol, C. Pering, C. H. Polman, H. E. de Vries, J. J.G. Geurts, et al.
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
Brain, March 1, 2008; 131(3): 800 - 807.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Saleh, M. Schroeter, A. Ringelstein, H.-P. Hartung, M. Siebler, U. Modder, and S. Jander
Iron Oxide Particle-Enhanced MRI Suggests Variability of Brain Inflammation at Early Stages After Ischemic Stroke
Stroke, October 1, 2007; 38(10): 2733 - 2737.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. D. Oude Engberink, S. M. A. van der Pol, E. A. Dopp, H. E. de Vries, and E. L. A. Blezer
Comparison of SPIO and USPIO for in Vitro Labeling of Human Monocytes: MR Detection and Cell Function
Radiology, May 1, 2007; 243(2): 467 - 474.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Bendszus, C. Kleinschnitz, and G. Stoll
Iron-Enhanced MRI in Ischemic Stroke: Intravascular Trapping Versus Cellular Inflammation
Stroke, May 1, 2007; 38(5): e12 - e12.
[Full Text] [PDF]


Home page
StrokeHome page
M. Wiart, N. Davoust, V. Desestret, N. Nighoghossian, and Y. Berthezene
Response to Letter by Bendszus et al
Stroke, May 1, 2007; 38(5): e13 - e13.
[Full Text] [PDF]


Home page
StrokeHome page
S. Jander, M. Schroeter, and A. Saleh
Imaging Inflammation in Acute Brain Ischemia
Stroke, February 1, 2007; 38(2): 642 - 645.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. Nighoghossian, M. Wiart, S. Cakmak, Y. Berthezene, L. Derex, T.-H. Cho, C. Nemoz, F. Chapuis, G.-L. Tisserand, J.-B. Pialat, et al.
Inflammatory Response After Ischemic Stroke: A USPIO-Enhanced MRI Study in Patients
Stroke, February 1, 2007; 38(2): 303 - 307.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Wiart, N. Davoust, J.-B. Pialat, V. Desestret, S. Moucharrafie, T.-H. Cho, M. Mutin, J.-B. Langlois, O. Beuf, J. Honnorat, et al.
MRI Monitoring of Neuroinflammation in Mouse Focal Ischemia
Stroke, January 1, 2007; 38(1): 131 - 137.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. J.S. Price, D. Wang, D. K. Menon, J. V. Guadagno, M. Cleij, T. Fryer, F. Aigbirhio, J.-C. Baron, and E. A. Warburton
Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke
Stroke, July 1, 2006; 37(7): 1749 - 1753.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
V. Dousset, B. Brochet, M.S.A. Deloire, L. Lagoarde, B. Barroso, J.-M. Caille, and K.G. Petry
MR Imaging of Relapsing Multiple Sclerosis Patients Using Ultra-Small-Particle Iron Oxide and Compared with Gadolinium.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1000 - 1005.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. M. Moghimi, A. C. Hunter, and J. C. Murray
Nanomedicine: current status and future prospects
FASEB J, March 1, 2005; 19(3): 311 - 330.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J.-C. Baron and S. Warach
Imaging
Stroke, February 1, 2005; 36(2): 196 - 199.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.